Human Gene Sequencing Market Report 2022: Featuring Key Players Abbott Diagnostics, 23andME, Eurofins Scientific & Others

DUBLIN, July 7, 2022 /PRNewswire/ -- The "Human Gene Sequencing Markets, Strategies & Trends - Forecasts by Application, by Technology, by Workflow, by Product, and by Country, with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.

The plummeting costs for Genome Sequencing is creating a gold rush. New consumers, new technologies, new market niches. It is reminiscent of the birth of the internet industry; a wide range of well funded players are racing for market share on a global stage. This report forecasts the market size out to 2026. The report includes detailed breakouts for 14 countries and 5 regions.

Key Topics Covered:

1 Market Guides

2 Introduction and Market Definition

3 Global Listing of Sequencer Installed Base - Location & Contacts

4 Market Overview
4.1 Market Participants Play Different Roles
4.2 Human Gene Sequencing -Markets, Examples and Discussion
4.2.1 Inherited Disease - Not what it used to be
4.2.2 Newborn Screening - The Standard of Care
4.2.3 NIPT - We've Only Just Begun
4.2.4 Oncology - Understanding Two Worlds
4.2.5 Pharmacogenomics
4.2.6 Direct To Consumer - More Than Meets the Eye
4.2.6.1 DTC - How Many Segments?
4.3 Industry Structure
4.3.1 Hospital's Testing Share
4.3.2 The Rise of the Sequencing Lab
4.3.3 Sequencing as a Commodity
4.3.4 Informatics
4.3.5 Instrument Manufacturer Role
4.3.6 Healthcare Industry Impacts - Still Struggling
4.3.7 Can the Healthcare Industry Adapt?
4.3.8 Genetic Counselling as an Industry
4.3.9 Sequencing Adoption and Cannibalization

5 Market Trends
5.1 Factors Driving Growth
5.1.1 New Diagnoses
5.1.2 Wellness and Prevention
5.1.3 Fertility Technology
5.1.4 Cancer - Screening, Management and Monitoring
5.2 Factors Limiting Growth
5.2.1 Increased Competition Lowers Price
5.2.2 Lower Costs
5.2.3 Healthcare Cost Concerns Curtail Growth
5.2.4 Wellness has a downside
5.3 Sequencing Instrumentation
3.3.1 Instrumentation Tenacity
3.3.2 Declining Cost of Instruments Changes Industry Structure
3.3.3 Listing of Current Instrument Specifications
5.3.1 Long Reads - Further Segmentation
5.3.2 Linked Reads
5.3.3 New Sequencing Technologies

6 Human Gene Sequencing Recent Developments

7 Profiles of Key Companies

8 The Global Market for Human Genome Sequencing
8.1 Global Market Overview by Country
8.2 Global Market by Application - Overview
8.3 Global Market by Technology - Overview
8.4 Global Market by Workflow - Overview
8.5 Global Market by Product - Overview

9 Market Sizes by Application
9.1 Hereditary Gene Sequencing Market
9.2 NIPT Gene Sequencing Market
9.3 Oncology Market
9.4 Psychology Market
9.5 WGES Gene Sequencing Market
9.6 Pharmacogenomics Market
9.7 DTC Gene Sequencing Market
9.8 Research Gene Sequencing Market
9.9 Other Application Market

10 Market Sizes by Technology
10.1 Sanger Sequencing Market
10.2 NGS/2G Market
10.3 3G/Long Market
10.4 Other Technology Market

11 Market Sizes by Workflow
11.1 Sequencing Market
11.2 Sample Prep Market
11.3 Analysis Market

12 Market Sizes by Product
12.1 Instruments Market
12.2 Consumables Market
12.3 Software & Services Market

13 Vision of the Future of Human Gene Sequencing

 Companies Mentioned

• 10x Genomics, Inc
• 23andME Inc
• Abbott Diagnostics
• AccuraGen Inc
• Adaptive Biotechnologies
• Admera Health, LLC
• Agena Bioscience, Inc
• Agilent
• Akonni Biosystems
• Ancestry.com LLC
• Anchor Dx
• Aperiomics
• Arc Bio
• ArcherDx, Inc
• ARUP Laboratories
• Asuragen
• Baylor Miraca Genetics Laboratories
• Beckman Coulter Diagnostics
• Becton, Dickinson and Company
• BGI Genomics Co. Ltd
• Bio-Rad Laboratories, Inc
• Bio-Techne
• Bioarray Genetics
• Biocept, Inc
• Biodesix Inc
• BioFluidica
• BioGenex
• Biolidics Ltd
• bioMerieux Diagnostics
• Bioneer Corporation
• C2i Genomics
• Cancer Genetics
• Caris Molecular Diagnostics
• CellMax Life
• Centogene
• Cepheid (now Danaher)
• Chronix Biomedical
• Circulogene
• Clinical Genomics
• Color Genomics
• Complete Genomics, Inc. - A BGI Company
• Cynvenio
• Dante Labs
• Datar Cancer Genetics Limited
• Diasorin S.p.A
• Epic Sciences
• Epigenomics AG
• Eurofins Scientific
• Excellerate Bioscience
• Exosome Diagnostics
• Fabric Genomics
• Fluidigm Corp
• Foundation Medicine
• Freenome
• FUJIFILM Wako Diagnostics
• Fujirebio
• Fulgent Genetics
• MDx Health
• Medgenome
• Meridian Bioscience
• Mesa Biotech
• MIODx
• miR Scientific
• MNG Labs
• Molecular MD
• NantHealth, Inc
• Natera
• Nebula Genomics
• NeoGenomics
• Novogene Bioinformatics Technology Co., Ltd
• Omega Bioservices
• OncoDNA
• OpGen
• ORIG3N, Inc
• Origene Technologies
• Oxford Nanopore Technologies
• Panagene
• Sure Genomics, Inc
• Sysmex Inostics
• Sysmex
• Tempus Labs, Inc.
• Thermo Fisher Scientific Inc
• Veritas Genetics
• Volition

For more information about this report visit https://www.researchandmarkets.com/r/yg9vcb

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets